CytomX Therapeutics
CTMX
CTMX
83 hedge funds and large institutions have $303M invested in CytomX Therapeutics in 2025 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
59% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 17
26% more funds holding
Funds holding: 66 → 83 (+17)
Holders
83
Holding in Top 10
–
Calls
$2.09M
Puts
$362K
Top Buyers
| 1 | +$22.5M | |
| 2 | +$14.7M | |
| 3 | +$13.6M | |
| 4 |
CC
Commodore Capital
New York
|
+$12.4M |
| 5 |
PA
Perceptive Advisors
New York
|
+$11.3M |
Top Sellers
| 1 | -$4.18M | |
| 2 | -$3.32M | |
| 3 | -$2.7M | |
| 4 |
CPC
Congress Park Capital
Saratoga Springs,
New York
|
-$932K |
| 5 |
LCM
Laurion Capital Management
New York
|
-$823K |